Avenue raises $33M in IPO

Neurology company Avenue Therapeutics Inc. (NASDAQ:ATXI) raised $33 million through the sale of 5.5 million shares at $6 in an IPO underwritten by Oppenheimer and the National Securities Corp. subsidiary of National Holdings Inc. (NASDAQ:NHLD) on June 26. In an earlier June amendment, Oppenheimer replaced Raymond James as an underwriter...